Aromatase inhibitors (AIs) are a class of drugs that block the aromatase enzyme ... These medications have gained attention in the treatment of short stature, particularly in children experiencing ...

has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with ...

Purpose. The clinical and economic benefits of aromatase inhibitor (AI) therapy in early-stage breast cancer are reviewed. Summary. AI therapy has become a standard of care for the treatment of ...

Theoretically, you could put any number of chemotherapy drugs in these packets ... or beginning treatment with tamoxifen and switching to an aromatase inhibitor after two to five years.

Aromatase inhibitors (AIs) are a common treatment for hormone receptor-positive ... a nonsteroidal anti-inflammatory drug (NSAID), which has shown potential in improving stiffness and quality ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered investigational drug imlunestrant ... an aromatase inhibitor (AI) therapy ...

Arimidex has also been approved as adjuvant therapy -- drugs given after surgery or radiation-- for women with certain types of early breast cancer. Aromatase inhibitors work differently than ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Ovarian cancer, often called the silent killer, presents one of the most serious health threats women face globally. Its ...

Breast carcinoma remains the most common malignancy of women around the world, and despite the advances in the early diagnosis and adjuvant treatment ... to the aromatase inhibitors in patients ...

A research team at the ICR has now identified a set of new biomarkers that A predictive test for personalising breast cancer treatment predict resistance to aromatase inhibitors in ER+/HER2+ tumours ...